Led by Zach Rosenthal, our Research Grant “Neuromodulation for Dravet Syndrome: Preclinical Validation of a Novel Therapeutic Mechanism ” has been approved for funding by Dravet Syndrome Foundation (DSF). This Grant will support Zach’s work studying basic mechanisms of ECT and the potential use of ECT to treat endophenotypes of Dravet Syndrome in a mouse model (and potentially in human patients).